ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Lohoff M, Gessner A, Bogdan C, Röllinghoff M, 1998. The Th1/Th2 paradigm and experimental murine leishmaniasis. Int Arch Allergy Immunol 115 :191–202.
-
2
Solbach W, Laskay T, 2000. The host response to Leishmania infection. Adv Immunol 74 :275–317.
-
3
Alexander J, Bryson K, 2005. T helper (h)1/Th2 and Leishmania: Paradox rather than paradigm. Immunol Lett 99 :17–23.
-
4
Brown DR, Reiner SL, 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect Immun 67 :266–270.
-
5
Huber M, Timms E, Mak TW, Rollinghoff M, Lohoff M, 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun 66 :3968–3970.
-
6
Safe SS, 1990. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors. Crit Rev Toxicol 21 :51–88.
-
7
Zook DR, Rappe C, 1994. Environmental sources, distribution, and fate of polychlorinated dibenzodioxins, dibenzofurans, and related organochlorines. Schecter A, ed. Dioxins and Health. New York: Plenum Press.
-
8
Birnbaum LS, Tuomisto J, 2000. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17 :275–288.
-
9
Kerkvliet NI, 1995. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 103 (Suppl 9):47–53.
-
10
Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI, 2001. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171 :157–164.
-
11
Jeon MS, Esser C, 2000. The murine IL-2 promoter contains distal regulatory elements reponsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 165 :6975–6983.
-
12
Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M, 1999. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160 :141–155.
-
13
Prell RA, Kerkvliet NI, 1997. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma. J Immunol 158 :2695–2703.
-
14
Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK, 1996. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 157 :2310–2319.
-
15
Titus RG, Ceredig R, Cerottini JC, Louis JA, 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 135 :2108–2114.
-
16
Yang DM, Fairweather N, Button LL, McMaster WR, Kahl LP, Liew FY, 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol 145 :2281–2285.
-
17
Lima HC, Bleyenberg JA, Titus RG, 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13 :80–83.
-
18
Warren TK, Mitchell KA, Lawrence BP, 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56 :114–123.
-
19
Shepherd DM, Dearstyne EA, Kerkvliet NI, 2000. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4+ T cells in adoptively transferred mice. Toxicol Sci 56 :340–350.
-
20
Ito T, Inouye K, Fujimaki H, Tohyama C, Nohara K, 2002. Mechanism of TCDD-induced suppression of antibody production: Effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol Sci 70 :46–54.
-
21
Chakkalath HR, Titus RG, 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153 :4378–4387.
-
22
Mbow ML, DeKrey GK, Titus RG, 2001. Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol 31 :1400–1409.
-
23
Alsharif NZ, Schlueter WJ, Stohs SJ, 1994. Stimulation of NADPH-dependent reactive oxygen species formation and DNA damage by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat peritoneal lavage cells. Arch Environ Contam Toxicol 26 :392.
-
24
Alsharif NZ, Lawson T, Stohs SJ, 1994. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin is mediated by the aryl hydrocarbon (Ah) receptor complex. Toxicology 92 :39–51.
-
25
Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 :248–257.
-
26
Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 :126–132.
-
27
van Grevenynghe J, Sparfel L, Le Vee M, Gilot D, Drenou B, Fauchet R, Fardel O, 2004. Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem Biophys Res Commun 317 :708–716.
-
28
Mantovani A, Vecchi A, Luini W, Sironi M, Candiani GP, Spreafico F, Garattini S, 1980. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell mediated cytotoxicity in mice. Biomedicine 32 :200–204.
-
29
Vos JG, Kreeftenberg JG, Engel HWB, Minderhoud A, Van Noorle Jansen LM, 1978. Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: Endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 9 :75–86.
-
30
Nacy CA, Meierovies AI, Belosevic M, Green SJ, 1991. Tumor necrosis factor-alpha: Central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology 59 :182–184.
-
31
Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): Phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 :248–257.
-
32
Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 :126–132.
-
33
Sugita-Konishi Y, Kobayashi K, Naito H, Miura K, Suzuki Y, 2003. Effect of lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 67 :89–93.
-
34
Tucker AN, Vore SJ, Luster MI, 1986. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29 :372–377.
-
35
Hahn ME, 2002. Aryl hydrocarbon receptors: Diversity and evolution. Chem Biol Interact 141 :131–160.
-
36
Birnbaum LS, 1986. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab Dispos 14 :34–40.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 391 | 366 | 12 |
| Full Text Views | 218 | 5 | 1 |
| PDF Downloads | 52 | 5 | 1 |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) REDUCES LEISHMANIA MAJOR BURDENS IN C57BL/6 MICE
OWEN J. BOWERS
OWEN J. BOWERS
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by OWEN J. BOWERS in
Current site
Google Scholar
PubMed
Search for other papers by OWEN J. BOWERS in
Current site
Google Scholar
PubMed
KIRSA B. SOMMERSTED
KIRSA B. SOMMERSTED
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by KIRSA B. SOMMERSTED in
Current site
Google Scholar
PubMed
Search for other papers by KIRSA B. SOMMERSTED in
Current site
Google Scholar
PubMed
RYAN T. SOWELL
RYAN T. SOWELL
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by RYAN T. SOWELL in
Current site
Google Scholar
PubMed
Search for other papers by RYAN T. SOWELL in
Current site
Google Scholar
PubMed
GRETCHEN E. BOLING
GRETCHEN E. BOLING
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by GRETCHEN E. BOLING in
Current site
Google Scholar
PubMed
Search for other papers by GRETCHEN E. BOLING in
Current site
Google Scholar
PubMed
WILLIAM H. HANNEMAN
WILLIAM H. HANNEMAN
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by WILLIAM H. HANNEMAN in
Current site
Google Scholar
PubMed
Search for other papers by WILLIAM H. HANNEMAN in
Current site
Google Scholar
PubMed
RICHARD G. TITUS
RICHARD G. TITUS
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by RICHARD G. TITUS in
Current site
Google Scholar
PubMed
Search for other papers by RICHARD G. TITUS in
Current site
Google Scholar
PubMed
GREGORY K. DEKREY
GREGORY K. DEKREY
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; Department of Biological Sciences, College of Natural and Health Sciences, University of Northern Colorado, Greeley, Colorado; Department of Immunology, University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas; Department of Environmental and Radiological Health Sciences and Department of Microbiology, Immunology and Pathology, College of Veterinary and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
Search for other papers by GREGORY K. DEKREY in
Current site
Google Scholar
PubMed
Search for other papers by GREGORY K. DEKREY in
Current site
Google Scholar
PubMed
Acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can suppress adaptive immunity. In this study, pre-exposure of Leishmania major–infected mice to TCDD caused a dose-dependent and unexpected decrease in parasite burdens on day 20 after infection. In contrast, TCDD-mediated lymphoid atrophy, suppressed antibody levels, and enhanced interleukin-2 production were observed as expected. These results suggest that TCDD may enhance resistance to L. major in the face of immune suppression.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Lohoff M, Gessner A, Bogdan C, Röllinghoff M, 1998. The Th1/Th2 paradigm and experimental murine leishmaniasis. Int Arch Allergy Immunol 115 :191–202.
-
2
Solbach W, Laskay T, 2000. The host response to Leishmania infection. Adv Immunol 74 :275–317.
-
3
Alexander J, Bryson K, 2005. T helper (h)1/Th2 and Leishmania: Paradox rather than paradigm. Immunol Lett 99 :17–23.
-
4
Brown DR, Reiner SL, 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect Immun 67 :266–270.
-
5
Huber M, Timms E, Mak TW, Rollinghoff M, Lohoff M, 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun 66 :3968–3970.
-
6
Safe SS, 1990. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors. Crit Rev Toxicol 21 :51–88.
-
7
Zook DR, Rappe C, 1994. Environmental sources, distribution, and fate of polychlorinated dibenzodioxins, dibenzofurans, and related organochlorines. Schecter A, ed. Dioxins and Health. New York: Plenum Press.
-
8
Birnbaum LS, Tuomisto J, 2000. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17 :275–288.
-
9
Kerkvliet NI, 1995. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 103 (Suppl 9):47–53.
-
10
Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI, 2001. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171 :157–164.
-
11
Jeon MS, Esser C, 2000. The murine IL-2 promoter contains distal regulatory elements reponsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 165 :6975–6983.
-
12
Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M, 1999. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160 :141–155.
-
13
Prell RA, Kerkvliet NI, 1997. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma. J Immunol 158 :2695–2703.
-
14
Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK, 1996. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 157 :2310–2319.
-
15
Titus RG, Ceredig R, Cerottini JC, Louis JA, 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 135 :2108–2114.
-
16
Yang DM, Fairweather N, Button LL, McMaster WR, Kahl LP, Liew FY, 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol 145 :2281–2285.
-
17
Lima HC, Bleyenberg JA, Titus RG, 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13 :80–83.
-
18
Warren TK, Mitchell KA, Lawrence BP, 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56 :114–123.
-
19
Shepherd DM, Dearstyne EA, Kerkvliet NI, 2000. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4+ T cells in adoptively transferred mice. Toxicol Sci 56 :340–350.
-
20
Ito T, Inouye K, Fujimaki H, Tohyama C, Nohara K, 2002. Mechanism of TCDD-induced suppression of antibody production: Effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol Sci 70 :46–54.
-
21
Chakkalath HR, Titus RG, 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153 :4378–4387.
-
22
Mbow ML, DeKrey GK, Titus RG, 2001. Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol 31 :1400–1409.
-
23
Alsharif NZ, Schlueter WJ, Stohs SJ, 1994. Stimulation of NADPH-dependent reactive oxygen species formation and DNA damage by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat peritoneal lavage cells. Arch Environ Contam Toxicol 26 :392.
-
24
Alsharif NZ, Lawson T, Stohs SJ, 1994. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin is mediated by the aryl hydrocarbon (Ah) receptor complex. Toxicology 92 :39–51.
-
25
Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 :248–257.
-
26
Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 :126–132.
-
27
van Grevenynghe J, Sparfel L, Le Vee M, Gilot D, Drenou B, Fauchet R, Fardel O, 2004. Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem Biophys Res Commun 317 :708–716.
-
28
Mantovani A, Vecchi A, Luini W, Sironi M, Candiani GP, Spreafico F, Garattini S, 1980. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell mediated cytotoxicity in mice. Biomedicine 32 :200–204.
-
29
Vos JG, Kreeftenberg JG, Engel HWB, Minderhoud A, Van Noorle Jansen LM, 1978. Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: Endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 9 :75–86.
-
30
Nacy CA, Meierovies AI, Belosevic M, Green SJ, 1991. Tumor necrosis factor-alpha: Central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology 59 :182–184.
-
31
Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): Phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 :248–257.
-
32
Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 :126–132.
-
33
Sugita-Konishi Y, Kobayashi K, Naito H, Miura K, Suzuki Y, 2003. Effect of lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 67 :89–93.
-
34
Tucker AN, Vore SJ, Luster MI, 1986. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29 :372–377.
-
35
Hahn ME, 2002. Aryl hydrocarbon receptors: Diversity and evolution. Chem Biol Interact 141 :131–160.
-
36
Birnbaum LS, 1986. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab Dispos 14 :34–40.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 391 | 366 | 12 |
| Full Text Views | 218 | 5 | 1 |
| PDF Downloads | 52 | 5 | 1 |